Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Dialysis

 

Fresenius shares jump 5% on 2019 results as Helios beats expectations

Listed dialysis, pharma and hospital group Fresenius has seen a 6% jump in its share price after 2019 results were better than some analysts expected. But with significant Asia exposure in certain businesses, CEO Stephan Sturm says: "Coronavirus is not going to be a positive for us."
February 20, 2020

Mini dialysis device maker raises $40m

We talk to the CEO of AWAK, a Singaporean medtech group that has developed a portable peritoneal dialysis device, which just raised $40m to accelerate its development and commercialisation in the US and internationally. What does it say about investor appetite for dialysis, considering the slow Diaverum sale process?
January 30, 2020

Bridgepoint seeks IPO for Diaverum

Bridgepoint is reportedly pitching to banks for an IPO of its international dialysis provider Diaverum after a failed private auction, HBI is told. We name likely second-round participants, reasons why they might have pulled out, and whether Diaverum can better the valuations of listed peers.
January 23, 2020

Interview: Thierry Chiche, CEO, Elsan

HBI talks to the CEO of Elsan, France's second-largest private hospital group and the largest private equity-owned one by revenue outside of the US, as it approaches its sixth - and possibly final - year of ownership by CVC. In this wide-ranging interview, Chiche discusses the group's strategy, the French market and exclusively reveals its latest acquisition.
January 15, 2020

FREE BLOG After Christmas come the New Year sales

Christmas is fast approaching, and hot on its heels, the New Year sales. Here at HBI, we like a high street deal as much as the next man, but it’s what’s in the healthcare services pipeline in 2020 that’s caught our eye today.
December 19, 2019

Brazilian M&A shows “territory war” for the South

This year, Brazilian healthcare has been characterised by a flurry of activity from two vertically integrated insurers in particular. The most intense competition has occurred in the affluent South, where providers are battling it out for market share.
December 5, 2019

Investcorp bets on NephroPlus

Bahrain-based Investcorp has invested $45m in Indian dialysis provider NephroPlus in a deal which HBI estimates gives it a triple-digit-$m valuation. We talk to CEO Vikram Vuppala.
November 29, 2019

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.
October 31, 2019

Diaverum auction starts; first-round bids in

The sale of global dialysis provider Diaverum has officially launched with first-round bids submitted earlier this month, HBI hears, and second-round offers expected in the next few weeks. Who has actually bid is much less clear, however, and owner Bridgepoint is keeping the IPO option open.
October 24, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us